Contract 75N98024A00057
A&G Pharmaceutical, Inc. · Department Of Health And Human Services · January 30, 2026
A&G Pharmaceutical, Inc. was awarded a federal contract by Department Of Health And Human Services (National Institutes Of Health) on January 30, 2026 for an undisclosed amount of work in pharmaceutical preparation manufacturing. It uses order dependent (idv allows pricing arrangement to be determined separately for each order) contract pricing. If all options are exercised, the contract could reach $10.00 million.
Contract details
- PIID
- 75N98024A00057
- Award type
- —
- Pricing
- Order Dependent (Idv Allows Pricing Arrangement To Be Determined Separately For Each Order)
- NAICS
- 325412 · Pharmaceutical Preparation Manufacturing
- Product / service
- Drugs And Biologicals
- First action
- January 30, 2026
Description
O/M ITEMS ONLY: BIOLOGICAL MATERIALS, LABORATORY & TESTING SERVICES, ANIMAL TESTING SERVICES
Modification timeline
-
January 30, 2026Mod P00003 · Other Administrative Action$0
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Four Points Technology, L.L.C. | Department Of Health And Human Services | March 31, 2026 | $246.6K |
| Astrazeneca Pharmaceuticals Lp | Department Of Health And Human Services | March 31, 2026 | $122.8K |
| Ase Direct, Inc. | Department Of Health And Human Services | March 30, 2026 | $49.0K |
| Emergent Biosolutions Canada Inc | Department Of Health And Human Services | March 30, 2026 | $256.40M |
| Mckesson Corporation | Department Of Health And Human Services | March 30, 2026 | $9.00M |
| Seqirus USA Inc | Department Of Health And Human Services | March 27, 2026 | $2.02M |
Top contractors in NAICS 325412
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Mckesson Corporation | 1,187 | $4.96B |
| 2 | Merck Sharp & Dohme Llc | 26 | $894.71M |
| 3 | Sanofi Vaccines Us Inc. | 57 | $702.38M |
| 4 | Pfizer Inc | 169 | $541.15M |
| 5 | Glaxosmithkline, Llc | 14 | $505.04M |
| 6 | Phlow Corp. | 1 | $105.27M |
| 7 | Exelan Pharmaceuticals Inc | 76 | $104.30M |
| 8 | Seqirus USA Inc | 47 | $59.15M |
| 9 | Emergent Biosolutions Canada Inc | 2 | $53.73M |
| 10 | Mckesson Specialty Distribution Llc | 1 | $51.05M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75N98024A00057?
Contract 75N98024A00057 is a federal contract awarded to A&G Pharmaceutical, Inc. by Department Of Health And Human Services on January 30, 2026 for an undisclosed amount of work classified under PHARMACEUTICAL PREPARATION MANUFACTURING. It has been modified 0 times since the base award.
Who won contract 75N98024A00057?
A&G Pharmaceutical, Inc. won contract 75N98024A00057 from Department Of Health And Human Services.
How much is contract 75N98024A00057 worth?
Contract 75N98024A00057 has obligated $0 to date but carries a potential ceiling of $10.00 million if fully funded and all options are exercised.